# Single Dose of pGM169/GL67A in CF Patients

> **NCT00789867** · PHASE1,PHASE2 · COMPLETED · sponsor: **Imperial College London** · enrollment: 35 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** pGM169/GL67A

## Key facts

- **NCT ID:** NCT00789867
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-08
- **Final completion:** 2010-12
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00789867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00789867, "Single Dose of pGM169/GL67A in CF Patients". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00789867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*